The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint.
Open accessAbstract
Interleukin 1 (IL-1) is a polypeptide released by activated macrophages and is thought to be a key mediator of host responses to infection and inflammation. The availability of highly purified and recombinant material has now permitted the evaluation of IL-1 as a mediator of chronic inflammatory processes in vivo. We have demonstrated that intraarticular injection of IL-1 into rabbit knee joints induces the accumulation of polymorphonuclear and mononuclear leukocytes in the joint space and the loss of proteoglycan from the articular cartilage. The effects on cartilage could not be explained solely by the presence of leukocytes, since injections of endotoxin also stimulated leukocyte accumulation in the joint but had no effect on proteoglycan loss. Responses to IL-1 were not associated with increased production of the icosanoids prostaglandin E2 or leukotriene B4 and were not reduced by an inhibitor of their synthesis. The pattern of leukocyte infiltration and cartilage breakdown 24 hr after IL-1 injection was similar to that seen in animals with antigen-induced arthritis of 1 week's duration. These observations support the hypothesis that IL-1 acts directly to mediate the erosive processes of chronic arthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Direct Spectrophotometric Microassay for Sulfated Glycosaminoglycans in Cartilage Cultures
Farndale, R. W., Sayers, C. A., & Barrett, A. J. (1982) · Connective Tissue Research · doi:10.3109/03008208209160269 · Cited by 1,347
Control of vascular permeability by polymorphonuclear leukocytes in inflammation
Wedmore, C. V., & Williams, T. J. (1981) · Nature · doi:10.1038/289646a0 · Cited by 849
A new approach to anti-inflammatory drugs
Higgs, G. A., Flower, R. J., & Vane, J. R. (1979) · Biochemical Pharmacology · doi:10.1016/0006-2952(79)90651-8 · Cited by 501
Self-citationThe production of arthritis in rabbits by an immunological reaction to fibrin.
Dumonde, D. C., & Glynn, L. E. (1962) · PubMed · Cited by 393
An update on human interleukin-1: From molecular biology to clinical relevance
Dinarello, C. A. (1985) · Journal of Clinical Immunology · doi:10.1007/bf00918247 · Cited by 374
PROSTAGLANDIN E2, PROSTAGLANDIN I2 AND THE VASCULAR CHANGES OF INFLAMMATION
WILLIAMS, T. J. (1979) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1979.tb07860.x · Cited by 344
A radioimmunoassay for 6-keto- prostaglandin F1α
Simon, J. A. (1978) · Prostaglandins · doi:10.1016/0090-6980(78)90122-3 · Cited by 317
Nouri, A. M. E., Panayi, G. S., & Goodman, S. M. (1984) · PubMed · Cited by 187
Dinarello, C. A., Marnoy, S. O., & Rosenwasser, L. J. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.2.890 · Cited by 185
The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production
Duff, G. W., & Atkins, E. (1982) · Journal of Immunological Methods · doi:10.1016/0022-1759(82)90005-9 · Cited by 176
Cited by
Cytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2094 · Cited by 2,529
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
Choy, E. H. S., & Panayi, G. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441207 · Cited by 2,249
Interleukin-1 and Its Biologically Related Cytokines
Dinarello, C. A. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60642-2 · Cited by 1,151
Dietary polyunsaturated fatty acids and inflammatory mediator production
James, M. J., Gibson, R. A., & Cleland, L. G. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.1.343s · Cited by 1,125
Eisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E., Brewer, M. T., Hannum, C. H., & Thompson, R. C. (1990) · Nature · doi:10.1038/343341a0 · Cited by 1,088
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis
Arend, W. P., & Dayer, J. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330302 · Cited by 949
Altered Cytokine Production in Mice Lacking P2X7Receptors
Solle, M., Labasi, J., Perregaux, D. G., Stam, E., Petrushova, N., Koller, B. H., Griffiths, R. J., & Gabel, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006781200 · Cited by 930
Horai, R., Saijo, S., Tanioka, H., Nakae, S., Sudo, K., Okahara, A., Ikuse, T., Asano, M., & Iwakura, Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.313 · Cited by 749
The balance between IL-1 and IL-1Ra in disease
Arend, W. P. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00020-5 · Cited by 721
The Role of Cytokines in Cartilage Matrix Degeneration in Osteoarthritis
Goldring, S. R., & Goldring, M. B. (2004) · Clinical Orthopaedics & Related Research · doi:10.1097/01.blo.0000144854.66565.8f · Cited by 654
Saxne, T., Palladino, M. A., Heinegãrd, D., Talal, N., & Wollheim, F. A. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310816 · Cited by 566
Rainsford, K. D., Parke, A. L., Clifford-Rashotte, M., & Kean, W. F. (2015) · Inflammopharmacology · doi:10.1007/s10787-015-0239-y · Cited by 543
Intra-articular treatment options for knee osteoarthritis
Jones, I. A., Togashi, R., Wilson, M. L., Heckmann, N., & Vangsness, C. T. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0123-4 · Cited by 525
Inflammation and the mechanism of action of anti‐inflammatory drugs
Vane, J., & Botting, R. (1987) · The FASEB Journal · doi:10.1096/fasebj.1.2.3111928 · Cited by 524
Zhu, G., Zhang, T., Chen, M., Yao, K., Huang, X., Zhang, B., Li, Y., Liu, J., Wang, Y., & Zhao, Z. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.03.043 · Cited by 494
CORRELATION OF PLASMA INTERLEUKIN 1 LEVELS WITH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS
Eastgate, J., Wood, N., Di Giovine, F., Symons, J., Grinlinton, F., & Duff, G. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90185-7 · Cited by 484
Kinin receptors in pain and inflammation
Couture, R., Harrisson, M., Vianna, R. M., & Cloutier, F. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01318-8 · Cited by 472
Jiranek, W. A., Machado, M., Jasty, M., Jevsevar, D., Wolfe, H. J., Goldring, S. R., Goldberg, M. J., & Harris, W. H. (1993) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199306000-00007 · Cited by 436
MacNaul, K. L., Chartrain, N., Lark, M., Tocci, M. J., & Hutchinson, N. I. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44894-0 · Cited by 399
Loo, F. A. J. V. D., Joosten, L. A. B., Van Lent, P. L. E. M., Arntz, O. J., & Van Den Berg, W. B. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380204 · Cited by 380
Anti-Cytokine Therapy for Rheumatoid Arthritis
Maini, R. N., & Taylor, P. C. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.207 · Cited by 376
Transforming growth factor-β regulates production of proteoglycans by mesangial cells
Border, W. A., Okuda, S., Languino, L. R., & Ruoslahti, E. (1990) · Kidney International · doi:10.1038/ki.1990.35 · Cited by 363
The Crystallization of Monosodium Urate
Martillo, M. A., Nazzal, L., & Crittenden, D. B. (2014) · Current Rheumatology Reports · doi:10.1007/s11926-013-0400-9 · Cited by 330
A genetic association between juvenile rheumatoid arthritis and a novel interleukin‐1α polymorphism
Mcdowell, T. L., Symons, J. A., Ploski, R., FØRre, Ø., & Duff, G. W. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380210 · Cited by 324
Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis
Baltzer, A. W. A., Moser, C., Jansen, S. A., & Krauspe, R. (2009) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.06.014 · Cited by 317
Collins, K. H., Herzog, W., MacDonald, G. Z., Reimer, R. A., Rios, J. L., Smith, I. C., Zernicke, R. F., & Hart, D. A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00112 · Cited by 308
Sacitharan, P. K. (2019) · Subcellular Biochemistry · doi:10.1007/978-981-13-3681-2_6 · Cited by 308
Selected cytokine pathways in rheumatoid arthritis
Noack, M., & Miossec, P. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0619-z · Cited by 303
Blood‐induced joint disease: the pathophysiology of hemophilic arthropathy
VALENTINO, L. A. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03962.x · Cited by 294
Bandara, G., Mueller, G. M., Galea-Lauri, J., Tindal, M. H., Georgescu, H. I., Suchanek, M. K., Hung, G. L., Glorioso, J. C., Robbins, P. D., & Evans, C. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10764 · Cited by 290
The Role of Cytokines as Inflammatory Mediators in Osteoarthritis: Lessons from Animal Models
Goldring, M. B. (1999) · Connective Tissue Research · doi:10.3109/03008209909005273 · Cited by 283
Tyler, J. A. (1989) · Biochemical Journal · doi:10.1042/bj2600543 · Cited by 277
Pro-and Anti-inflammatory Cytokines in Rheumatoid Arthritis
Isomäki, P., & Punnonen, J. (1997) · Annals of Medicine · doi:10.3109/07853899709007474 · Cited by 260
Cameron, M., Buchgraber, A., Passler, H., Vogt, M., Thonar, E., Fu, F., & Evans, C. H. (1997) · The American Journal of Sports Medicine · doi:10.1177/036354659702500605 · Cited by 257
Jobanputra, P., Barton, P., Bryan, S., & Burls, A. (2002) · Health Technology Assessment · doi:10.3310/hta6210 · Cited by 126
Metadata
- Authors
- Pettipher, E. R., Higgs, G. A., & Henderson, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1986-11
- Volume
- 83
- Issue
- 22
- Pages
- 8749-8753
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2145864210
- Cited by
- 496
- References
- 14
- FWCI
- 30.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.